Health

Allianz Partners urges travellers to rethink coverage as new data shows Aussies still travelling uninsured

BRISBANE, Australia, Oct. 22, 2025 /PRNewswire/ -- Allianz Partners is urging Australian travellers to rethink their approach to travel insurance, following new ICA and DFAT research revealing that one in seven travellers are still going overseas uninsured. The findings underscore Allianz Partner...

2025-10-22 08:00 1243

The Shaw Prize Award Presentation Ceremony 2025: Continuing 22 Years of Legacy in Science and Innovation

HONG KONG, Oct. 22, 2025 /PRNewswire/ -- The Shaw Prize presented its awards to four 2025 Shaw Laureates on 21 Oct at the 2025 Award Presentation Ceremony, held in the Grand Hall of the Hong Kong Convention and Exhibition Centre. Approximately 600 guests from various sectors participated in the e...

2025-10-22 01:17 1419

JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltène

SHANGHAI, Oct. 21, 2025 /PRNewswire/ -- China's leading multi-brand beauty group JOY GROUP (Shanghai Juyi Cosmetics Co., Ltd.) has announced the completion of its acquisition of Foltène, a dermatological hair care brand from Italy. Pr...

2025-10-21 22:00 1483

HKSH Medical Group to Host Hong Kong's First Asia-Oceania Particle Therapy Co-operative Group Conference

Best Practice by World-class Experts in Proton Therapy Transforming Precision Cancer Management HONG KONG, Oct. 21, 2025 /PRNewswire/ -- HKSH Medical Group (HKSH) introduced Hong Kong's only and the Greater Bay Area's first proton therapy system in 2023, after two decades of planning and prepara...

2025-10-21 16:02 1051

Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

GOTHENBURG, Sweden, Oct. 21, 2025 /PRNewswire/ -- "We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company's ...

2025-10-21 14:45 1183

Abbott and BIG CARiNG Group Launch Nationwide Influenza Awareness Program to Strengthen Public Health Response Through Early Intervention

KUALA LUMPUR, Malaysia, Oct. 21, 2025 /PRNewswire/ -- Abbott, a global healthcare leader, and BIG CARiNG Group (BCG), one ofMalaysia's largest retail pharmacies, announced a strategic three-year collaboration to promote influenza awareness acrossMalaysia. The Influenza Awareness Program, running ...

2025-10-21 13:12 1727

Biomom Partners with Kolmar BNH to Enhance "Biomom Snow" -- Upgrading Both Quality and Taste

SEOUL, South Korea, Oct. 21, 2025 /PRNewswire/ -- Health supplement brand Biomom has renewed its flagship children's probiotic, "Biomom Snow," with enhanced quality and improved flavor. As part of the renewal, Biomom selected Kolmar BNH Co., Ltd. as its new manufacturing partner, reinforcing its...

2025-10-21 11:00 865

Zero Formalin Specimen Preservation Solution for Formalin-Free Classrooms

BANGKOK, Oct. 21, 2025 /PRNewswire/ -- Anatomy instructors at the Faculty of Veterinary Science , Chulalongkorn University , have developed Zero Formalin (ZF)—a formalin-free animal specimen preservation solution—to creat...

2025-10-21 10:00 1017

Shimadzu Asia Pacific Celebrates 150th Anniversary -A Century and a Half of Driving Healthcare and Technological Breakthroughs

SINGAPORE, Oct. 21, 2025 /PRNewswire/ -- Shimadzu Asia Pacific joins the global celebration of Shimadzu Corporation 's 150th anniversary, marking a century and a half of pioneering innovations that have shaped science, technology, and hea...

2025-10-21 09:00 1195

NSG Bio Launches NSG BioSuites at Geneo - A New Product, Largest Site, and Fourth Location in Singapore

SINGAPORE, Oct. 21, 2025 /PRNewswire/ -- NSG Bio, a leading provider of flexible and high-quality biotech laboratory spaces, announced the launch of its latest product, NSG BioSuites, located at the brand-new Geneo development in Singapore Science Park. This marks NSG Bio's fourth site in Singapor...

2025-10-21 08:00 964

LabConnect Featured in Season Finale of Emmy-Nominated Series Tomorrow's World Today

JOHNSON CITY, Tenn., Oct. 21, 2025 /PRNewswire/ -- LabConnect, a leading provider of global central laboratory and support services for clinical trials, will be featured on the season 9 finale of the innovation-focused TV series, Tomorrow's World Today. Premiering on Science Channel on November 8,...

2025-10-21 01:11 944

Benchling Partners with Anthropic to Build a Bridge Between Science and AI

Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- Benchling today announced a partnership with ...

2025-10-21 00:00 1075

TraceLink Recognized on Fast Company's Next Big Things in Tech List

The annual list honors groundbreaking advancements redefining the way we work and live BOSTON, Oct. 20, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced its inclusion in Fast Company'sNext Big Thing...

2025-10-20 23:59 971

BTL's EMSCULPT NEO Used in Astronaut Training in Hungary for International Space Mission

PRAGUE, Oct. 20, 2025 /PRNewswire/ -- BTL, a global leader in medical technologies, proudly announces that its flagship device, EMSCULPT NEO, played a key role in astronaut preparation ahead of a historic spaceflight. As a result of the cooperation between BTL Hungary and HUNOR (Hungarian To Orbi...

2025-10-20 20:09 1184

Weaving a Network of Care Together: Jiahui International Hospital (Shanghai) and NYU Shanghai Unveil Cooperative Program

SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- On the morning of Oct. 18, 2025, during Jiahui Health's Breast Cancer Awareness Month program, Jiahui International Hospital (Shanghai) was officially recognized as an internship site for the Social Work program at NYU Shanghai. John K. HSIANG, MD, PhD, ch...

2025-10-20 20:03 1365

The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC

* After a median follow-up of 18.9 months, the median PFS was 8.3 months in the sac-TMT group and 4.3 months in the chemotherapy group (hazard ratio (HR), 0.49; 95% confidence interval (CI), 0.39 to 0.62; two-sided P<0.0001). * OS was significantly longer with sac-TMT than with chemotherapy (H...

2025-10-20 17:06 1185

ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma

BERLIN, Oct. 20, 2025 /PRNewswire/ -- At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing locally advanced or metastatic urothelial carcinoma (RC48-C016)...

2025-10-20 14:58 1286

Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions

LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This strategic move enhances Accord B.V.'s commitment to improving global a...

2025-10-20 14:00 1152

Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO

CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, Results from a Phase 3 study of the Company's human epidermal growth factor rece...

2025-10-20 13:59 976

Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer

SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- October 20, 2025- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrou...

2025-10-20 13:21 1067
1 ... 16171819202122 ... 562